Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paratek Pharmaceuticals (PRTK)
NASDAQ:PRTK
Holding PRTK?
Track your performance easily
PRTK Stock Chart & Stats
Day’s Range$2.19 - $2.24
52-Week Range― - ―
Previous Close$2.19
Volume4.76M
Average Volume (3M)N/A
Market Cap
$127.83M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.15Price Target Upside-3.59% Downside
Rating ConsensusHold
Number of Analyst Covering1
Paratek Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PRTK FAQ
What was Paratek Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Paratek Pharmaceuticals’s market cap?
Currently, no data Available
When is Paratek Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Paratek Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Paratek Pharmaceuticals overvalued?
According to Wall Street analysts Paratek Pharmaceuticals’s price is currently Overvalued.
Does Paratek Pharmaceuticals pay dividends?
Paratek Pharmaceuticals does not currently pay dividends.
What is Paratek Pharmaceuticals’s EPS estimate?
Paratek Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Paratek Pharmaceuticals have?
Currently, no data Available
What happened to Paratek Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Paratek Pharmaceuticals?
Among the largest hedge funds holding Paratek Pharmaceuticals’s share is Bruce & Co., Inc.. It holds Paratek Pharmaceuticals’s shares valued at 3M.
---
Paratek Pharmaceuticals Stock Smart Score
Company Description
Paratek Pharmaceuticals
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.
---
PRTK Stock 12 Month Forecast
Average Price Target
$2.15
▼(-3.59% Downside)
Best Analysts Covering PRTK
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-18.40%
reiterated a buy rating 2 years ago
Copying Robert Hazlett's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -18.40% per trade.
---